Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Health In Tech, a healthcare tech firm, gets a strong buy rating with a $2.50 target, shares open at $0.83.
Health In Tech (NASDAQ:HIT) received a "strong-buy" rating upgrade from Wall Street Zen and Maxim Group, which set a $2.50 price target.
The company, founded in 2014 and based in Florida, offers insurance technology for healthcare.
Recently, Health In Tech reported $0.01 earnings per share and $8.02 million in revenue, surpassing analyst revenue expectations but missing on earnings.
Shares opened at $0.83 on Friday.
2 Articles
Health In Tech, una firma de tecnología sanitaria, obtiene una fuerte calificación de compra con un objetivo de $2.50, las acciones se abren a $0.83.